Triall

Triall
(TRL)

$0.02781
(24h)‑$0.000058230.21%

About

Triall brings web 3.0 technology to clinical trials—medical research studies that test whether new medicines are safe and effective for humans. Clinical trial processes are notoriously costly and inefficient. They take many years, and involve increasing amounts of systems and data. The result is a lack of oversight, and uncertainty the integrity and authenticity of collected research data. It all drives the costs and reduces safety and reliability in the development of new medicines. Since early 2018, Triall has been working with clinical trial professionals to target these issues. Triall has developed software solutions that are integrated with blockchain technology. These solutions make clinical trials tamper-resistant, and enable secure integrations between the many isolated systems and parties involved in clinical trials. Hence, they promise to shape the world’s first digital ecosystem for clinical trials. Triall’s blockchain functionalities and ecosystem approach are unique in the 200-billion-dollar clinical trial industry. The project directly answers to growing calls for system interoperability and data traceability as voiced by regulators such as the FDA and EMA, and by a growing body of clinical trial professionals around the world. The project introduces a two-token system that functions as the ecosystem’s primary means of payment, while also facilitating community engagement, governance, and token lock-up incentives.

TRL Statistics

Market Cap
$490.99K

24h Vol
$12.09K

Dominance
0.00%

Current Supply
17658265

Day's Range
$0.02755$0.02801

52 Week Range
$0.01518$0.97042

Rank
1653

Max Supply
175000000

All Time High
$0.97042

% down from ATH
‑97.13%

Days since ATH
328

ROI

1D
‑0.21%
1W
1.42%
1M
49.73%
3M
60.81%
6M
‑67.21%
1Y
‑94.15%